Morfología y Biología Celular
Departamento
![Foto de Morfología y Biología Celular](/img/noimage.png)
![Foto de Instituto de Neurociencias del Principado de Asturias](/img/noimage_org.png)
Instituto de Neurociencias del Principado de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Neurociencias del Principado de Asturias (22)
2023
-
One-way or two-way sweet link between theobromine and depression?
BMC Psychiatry
-
The adenosine A2A receptor in the basal ganglia: Expression, heteromerization, functional selectivity and signalling
International Review of Neurobiology (Academic Press Inc.), pp. 49-71
-
The olfactory Olfr-78/51E2 receptor interacts with the adenosine A2A receptor. Effect of menthol and 1,8-cineole on A2A receptor-mediated signaling
Frontiers in Pharmacology, Vol. 14
2022
-
Genetic Inactivation of Free Fatty Acid Receptor 3 Impedes Behavioral Deficits and Pathological Hallmarks in the APPswe Alzheimer’s Disease Mouse Model
International Journal of Molecular Sciences, Vol. 23, Núm. 7
-
Plant-derived compounds, vitagens, vitagenes and mitochondrial function
PharmaNutrition
2021
-
Antixoxidant supplements versus health benefits of brief/intermittent exposure to potentially toxic physical or chemical agents
Current Issues in Molecular Biology, Vol. 43, Núm. 2, pp. 650-664
-
Cuprizone‐induced neurotoxicity in human neural cell lines is mediated by a reversible mitochondrial dysfunction: Relevance for demyelination models
Brain Sciences, Vol. 11, Núm. 2, pp. 1-16
-
Neuroprotective effect of apolipoprotein d in cuprizone-induced cell line models: A potential therapeutic approach for multiple sclerosis and demyelinating diseases
International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-23
2020
-
Adenosine a2a and a3 receptors are able to interact with each other. A further piece in the puzzle of adenosine receptor-mediated signaling
International Journal of Molecular Sciences, Vol. 21, Núm. 14, pp. 1-14
-
Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates
Brain Structure and Function, Vol. 225, Núm. 7, pp. 2153-2164
-
Expression of cannabinoid CB1R–GPR55 heteromers in neuronal subtypes of the Macaca fascicularis striatum
Annals of the New York Academy of Sciences, Vol. 1475, Núm. 1, pp. 34-42
-
Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson’s Disease
Frontiers in Aging Neuroscience, Vol. 12
-
Natural Compounds as Guides for the Discovery of Drugs Targeting G-Protein-Coupled Receptors
Molecules (Basel, Switzerland), Vol. 25, Núm. 21
2019
-
Antioxidant defense mechanisms in erythrocytes and in the central nervous system
Antioxidants, Vol. 8, Núm. 2
-
Antioxidants versus food antioxidant additives and food preservatives
Antioxidants, Vol. 8, Núm. 11
-
Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?
Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 9-16
-
Hormetic and mitochondria-related mechanisms of antioxidant action of phytochemicals
Antioxidants, Vol. 8, Núm. 9
-
Lessons on differential neuronal-death-vulnerability from familial cases of parkinson’s and alzheimer’s diseases
International Journal of Molecular Sciences, Vol. 20, Núm. 13
-
Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease
Molecular Neurobiology, Vol. 56, Núm. 8, pp. 5900-5910
-
Why have transgenic rodent models failed to successfully mimic Alzheimer’s disease. How can we develop effective drugs without them?
Expert Opinion on Drug Discovery